CTRI/2021/05/033845尚未招募未知
Fifth population based serosurveillance for SARS-CoV2 using IgG antibodies in Ahmedabad - AB5
Ahmedabad Municipal Corporation0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Those who give informed written consent
排除标准
- •any bleeding disorder, contraindication to venipuncture & hospitalized patients
研究者
相似试验
尚未招募
不适用
evel of IgG Antibodies against Covid19 in people of Ahmedabad as on February 2021CTRI/2021/02/031165Ahmedabad Municipal Corporation
已完成
不适用
Prospective data collection of SARS-CoV-2 positive tested employees of Klinken der Stadt Köln with post-infectious long-lasting symptoms (Long COVID) with the aim of characterization, quantification and analysis of the symptomsU09.9G93.3Post COVID-19 condition, unspecifiedPostviral fatigue syndromeDRKS00030178Institut für Hygiene Kliniken der Stadt Köln gGmbH Krankenhaus Merheim Klinikum der Universität Witten/Herdecke19
已完成
不适用
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies (Level42)COVID-19SARS-CoV-2 VirusCOVID-19 PneumoniaCOVID-19 Respiratory InfectionCOVID-19 Acute Respiratory Distress SyndromeCorona Virus InfectionInfluenzaRSV InfectionRespiratory InfectionCOVID-19 ARDSNCT05765396The Geneva Foundation300
尚未招募
不适用
Sero-surveillance for Dengue, Chikungunya and COVIDCTRI/2020/11/029141Shikha Dixit
尚未招募
不适用
Monitoring the trend of SARS-CoV-2, Dengue and Chikungunya infection transmission in the general population, IndiaCTRI/2021/01/030520Dr Guru Rajesh Jammy